Scientific Knowledge on the Subject: While oxygen supplementation and ventilation are used as therapy to improve oxygenation and the morbidity and mortality in acute lung injury (ALI ) patients, oxidant stress generated by hyperoxic ventilation or the initial injurious process itself is believed to play a major role in perpetuating ALI and prevent some patients from recovery. Direct antioxidant strategies to stoichiometrically scavenge the reactive electrophiles present in the lung of ALI patients or generated by hyperoxic ventilation therapy remain uncertain at best and the mortality associated with severe ALI remains significantly high around the world.
INTRODUCTION
Acute lung injury (ALI) or its most severe form acute respiratory distress syndrome (ARDS), affect up to 200,000 patients per year in the United States alone, with reported mortality rates of 35-40% (1, 2) . Many patients with ALI/ARDS require oxygen supplementation (leading to hyperoxia) to maintain adequate tissue oxygenation.
However, exposure to hyperoxia results in pathological features, such as lung inflammation and edema accompanied by epithelial and endothelial cell death (3), suggesting that oxygen supplementation, although beneficial, may potentially further perpetuate or exacerbate ALI (4) . Moreover hyperoxia has been shown to enhance lung susceptibility to subsequent bacterial or viral infections (5) . Several studies have shown that oxidative stress, generated in response to hyperoxia mainly, contributes to ALI (6) .
The Nrf2 transcription factor upregulates the expression of genes encoding several antioxidant enzymes and proteins (6) . Through a genetic linkage analysis, we first identified Nrf2 as an important candidate gene that regulates hyperoxic lung injury (7) . We have further demonstrated that mice with genetic disruption of Nrf2 have greater susceptibility to hyperoxic lung injury compared to wild type controls (8) . Recently, we have shown that Nrf2-deficiency impairs the resolution of lung injury and inflammation in response to nonlethal hyperoxic insult (9) . Nrf2 deficiency enhances lung alveolar epithelial cell death, and its overexpression in cells confers protection against oxidant induced pro-apoptotic stimuli such as hyperoxia (10, 11) . These studies underscore an important role for Nrf2-regulated gene transcription in conferring protection against hyperoxic insult.
Nrf2 binds to the antioxidant response element (ARE) with a consensus sequence 5'-a/gTGAC/GNNNGCa/g-3' commonly found in the regulatory regions (promoter and/or enhancers) of genes encoding several cytoprotective enzymes and proteins, and upregulates their transcription in response to a variety of stimuli (12) . In unstressed cells, 3 Nrf2 is predominantly localized in the cytoplasm in association with Kelch-like ECHassociated protein 1(Keap1), which promotes proteasomal degradation of Nrf2 (13) .
Keap1 sequesters Nrf2 in the cytoplasm by binding to the N-terminal Neh2 domain, thus preventing nuclear accumulation of Nrf2 (14) . Oxidant or toxic insults may perturb the tertiary structure of Keap1, thereby impeding Nrf2 degradation and facilitating Nrf2 nuclear accumulation and subsequent ARE-mediated transcription (15) . We have previously demonstrated that a synthetic triterpenoid compound CDDO-Im (1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl] imidazole) disrupts the cytosolic Keap1:Nrf2 interactions and robustly induces cytoprotective gene expression via Nrf2-ARE signaling in several tissues, including the lung (16) (17) (18) . In this study, we have investigated whether targeting the activation of Nrf2-dependent ARE-regulated gene transcription by CDDO-Im would provide a therapeutic strategy to attenuate ALI in vivo. Here, we provide experimental evidence demonstrating that administration of CDDO-Im during the period of exposure to hyperoxia protects against ALI suggesting that this compound may represent a new therapeutic strategy to minimize the adverse effects of hyperoxia in the treatment of ALI/ARDS patients. ) and wild type (Nrf2 +/+ ) CD1/ICR mice (7-8 weeks old, ~30 gms) (19) were exposed to hyperoxia as previously described (9) . Type II cells from lungs of Nrf2 -/-and Nrf2 +/+ mice were isolated and cultured as detailed in our previous publication (11). (See online data supplement for details)
Supplementation of pharmacologic inhibitors:
The synthetic triterpenoid CDDO-Im, which is known to disrupt the cytosolic Keap1:Nrf2 interaction, was synthesized as detailed elsewhere (17, 18) . CDDO-Im was freshly dissolved in PBS containing 10%
DMSO and 10% Cremophor-EL and then briefly sonicated to prepare a uniform µmoles/kg in the lung (18) . We therefore chose an optimal dose of 30 µmoles/kg body weight for the present study.
Assessment of lung permeability and inflammation:
To measure lung injury and inflammation, animals were administered at the end of experiments a lethal dose of the anesthetic agent pentobarbital and the right lung was instilled with 1.5 ml (0.75 ml each time/twice) of sterile PBS, and cells in the bronchoalveolar (BAL) fluid counted using a hemocytometer as previously described (9) . Differential cell counts were assessed with 
Real time RT-PCR analyses:
For RNA isolation, the left lung was quickly frozen and stored in RNAlater. Total RNA was isolated and reverse transcribed using superscript TM first strand cDNA synthesis system (Invitrogen Corp., CA), and real time RT-PCR reactions were performed using TaqMan ® gene expression assays for Nqo1, Gclc, Gclm, Ccnd1, p21 and Il-6 (Applied Biosystems, CA).
Statistical analysis:
Data were expressed as the mean ± SD. One-way ANOVA followed by Newman-Kuels post hoc analysis was performed for multiple group comparisons using Graphpad Prism software. For comparing the interaction between hyperoxia exposure and CDDO-Im treatment, two-way ANOVA with a Bonferroni correction was used.
Student's two-tailed t-test was used to determine the significant differences between different experimental groups in real-time PCR and TUNEL assays. "P" values with < 0.05 were considered as statistically significant for all experimental groups. *, indicates significance between room air vs. hyperoxia; §, between vehicle vs CDDO-Im, and †,
Nrf2
+/+ vs. Nrf2 -/-mice (see online data supplemental for additional details).
RESULTS

Supplementation of mice with CDDO-Im prior to and during hyperoxia dampens ALI
The wild type (Nrf2 +/+ ) CD1 mice were dosed with CDDO-Im at -48 h, -24 h and 0 h, as outlined in the schematic (Panel A, Fig.1 ), and were then exposed to 95% oxygen for 72 h.
This regimen of hyperoxia exposure was selected as it is known to cause significant and reproducible ALI in several mouse strains (20, 21) . During hyperoxia exposure, mice were Pretreatment of mice with CDDO-Im does not prevent ALI 7 To determine whether CDDO-Im pretreatment alone is sufficient to confer protection against hyperoxic lung injury, mice were fed with CDDO-Im at -48 h, -24 h and 0 h, and then exposed to 95% oxygen for 72 h as outlined in the schematic (panel A, Fig. 2 ). Mice were not treated with CDDO-Im during the hyperoxic exposure. As expected, there was greater level of lung hemorrhage and edema in mice exposed to hyperoxia compared to room air controls (Fig. 2B , see Figure E2 for enlarged images). We found no striking difference in lung histopathology between the CDDO-Im and vehicle treated mice after hyperoxia. The histologic staining showed a comparable level of hemorrhage and edema in the lung tissue of mice pretreated with CDDO-Im or vehicle following hyperoxic insult.
Consistent with this result, the BAL protein analysis revealed no significant difference in hyperoxia-induced lung alveolar permeability between mice pretreated with CDDO-Im and vehicle ( Fig. 2C ). Hyperoxia-induced neutrophil accumulation in the BAL fluid did not differ significantly between the two experimental groups (Fig. 2D ). However, we found modest but statistically significant differences in the levels of macrophages and total cells between CDDO-Im treated and vehicle treated hyperoxia experimental groups under this dosing regimen. These results suggest that pretreatment with CDDO-Im does not confer protection against hyperoxic lung injury or neutrophilic inflammation.
CDDO-Im treatment solely during hyperoxia confers potent protection against ALI
To determine the potential beneficial effects of CDDO-Im therapy in clinical setting, in this set experiments, Nrf2 +/+ mice were administered CDDO-Im at 0 h and then immediately exposed to 95% oxygen as outlined in the schematic (Fig. 3A) . Likewise, we dosed Nrf2 
CDDO-Im activates Nrf2-dependent gene transcription in the lung
We have previously reported that CDDO-Im at low doses enhances Nrf2-regulated gene expression in multiple tissues, including the lung (18) . Gclc, Nqo1 and Gpx2 are prototypic transcriptional targets of Nrf2 and are also known to attenuate oxidative stress (6) . Herein, we analyzed the levels of mRNA expression of these genes in lungs of Nrf2
and Nrf2 -/-mice dosed with and without CDDO-Im as in Fig. 3 . As shown in Fig. 4 
CDDO-Im blocks hyperoxia-induced lung cellular DNA damage
Because hyperoxia causes alveolar epithelial and endothelial cell damage (24), we assessed the extent of cellular injury and the expression levels of p21, which regulates DNA repair, in the lungs of Nrf2 +/+ and Nrf2 -/-mice exposed to hyperoxia with and without CDDO-Im treatment (Fig. 5 ). As expected, we found a greater number of TUNEL-positive cells (~ 30/field) in the lungs of hyperoxia exposed Nrf2 +/+ and Nrf2 -/-mice ( Fig. 5A left panel, see Figure E4 for enlarged fluorescent images), while TUNEL-staining was undetectable or low in the lungs of room air exposed mice (data not shown). However, the number of hyperoxia-induced TUNEL-positive cells was markedly lower in the lungs of 10 Nrf2 +/+ mice treated with CDDO-Im compared to counterpart Nrf2 -/-mice (Fig. 5A, right panel). Expression levels of p21 were elevated 4-fold in response to hyperoxic exposure in Nrf2 +/+ mice (Fig. 5B) . However, the mRNA induction of p21 by hyperoxia was more pronounced in mice treated with CDDO-Im (bar 6) than in vehicle treated-counterparts (bar 5). In contrast, CDDO-Im did not induce p21 expression in Nrf2 -/-mice in response to hyperoxia when compared with vehicle control (Fig. 5B , compare bar 7 and bar 8). We also analyzed the expression levels of Il-6, a pro-inflammatory cytokine, in the lungs of hyperoxia exposed mice with and without triterpenoid administration (Fig. 5C ). We found 
DISCUSSION
We have previously reported that disruption of Nrf2-ARE signaling enhances susceptibility to hyperoxic insult (8, 9) and that there is an association between a polymorphism in the NRF2 promoter and increased susceptibility to ALI in humans (25) . Exposure to 95% oxygen for 72 h has been shown to cause lung injury and inflammation, but the severity of hyperoxia-induced ALI varies in different strains of mice. BALB/cJ mice are more susceptible to hyperoxia exposure than 129/Svlm, C57BL/6J, and C3H/HeJ mice (7, 20, 21, 29) . Hyperoxia caused a 5-, 4-, 3-, 2.5-fold increase in BAL protein accumulation in BALB/cJ, 129/Svlm, C57BL/6J, and C3H/HeJ mice, respectively (7, 20, 21, 29) . DBA/2J and FVB/NJ mice, which are relatively resistant to hyperoxia, exhibited a 2-fold increase in BAL protein accumulation. In our experimental conditions, exposure of CD1 mice to hyperoxia for 72 h caused a significant increase in alveolar protein leak (~3 to 6-fold increase over room air control). However, disruption of Nrf2 in CD1 mice increased susceptibility to hyperoxia and caused severe ALI (8, 9) . Several studies have shown that hyperoxia causes DNA damage resulting in lung epithelial and endothelial cell death, which in turn leads to dysfunction of the lung vasculature and alveolar barrier as well as respiratory impairment (30) . We found that a simultaneous administration of CDDO-Im along with noxious exposure attenuates hyperoxia-induced lung cellular injury, assessed by TUNEL assay in Nrf2 +/+ but not Nrf2 -/-mice ( ) and wild type (Nrf2 +/+ ) CD1/ICR mice (7-8 weeks old, ~30 gms) (E1) were exposed to hyperoxia as previously described (E2).
Briefly, mice were placed in a glass exposure chamber (Biospherix Ltd, NY, USA) lined with sufficient CO 2 absorbent (Soda-sorb; WR Grace, Lexington, MA) and exposed to 95%
oxygen. Food and water were provided ad libitum. mice were isolated and cultured as detailed in our previous publication (E3).
Supplementation of pharmacologic inhibitors:
The synthetic triterpenoid CDDO-Im, which is known to disrupt the cytosolic Keap1:Nrf2 interaction, was synthesized as 
Real time RT-PCR analyses:
For RNA isolation, the left lung was quickly frozen and stored in RNAlater. Total RNA was isolated and reverse transcribed using superscript TM first strand cDNA synthesis system (Invitrogen Corp., CA), and real time RT-PCR reactions were performed using TaqMan ® gene expression assays for Nqo1, Gclc, Gclm, Ccnd1, p21 and Il-6 purchased from Applied Biosystems. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and mitochondrial ribosomal protein L32 (Mrpl32) were used as internal control genes The absolute expression values for each gene were normalized to that of Gapdh/Mrpl32 and the relative value for the vehicle control group was set as one.
Statistical analysis: Mice in various experimental groups were assigned arbitrary numbers during tissue and BAL collection. Protein estimation and cell counting as well as TUNEL analysis were performed using these numbers with the operator blinded as to the origin of the samples. After data collection, the results were grouped under each genotype, treatment and exposure category before performing statistical analysis. Data were expressed as the mean ± SD. Analysis of variance (ANOVA) was used for multiple group comparisons. One-way ANOVA followed by Newman-Kuels post hoc analysis was performed for multiple group comparisons using Graphpad Prism software. For comparing the interaction between hyperoxia exposure and CDDO-Im treatment, two-way ANOVA with a Bonferroni correction was used. Student's two-tailed t-test was used to determine statistical significance between different experimental groups in real-time PCR and TUNEL assays. "P" values with < 0.05 were considered as significant.
Supplemental Figure Legends
Figure E1: Nrf2 +/+ (wild-type) mice were administered CDDO-Im or vehicle every 24 h interval prior to and during hyperoxia exposure as outlined in Figure 1A . After exposure to 95% oxygen for 72 h, mice were sacrificed and the left lung was fixed and stained with H&E for lung histopathology. A representative image at 40x magnification of three mice is shown. Figure E2 : Nrf2 +/+ (wild-type) mice were administered CDDO-Im or vehicle at 24 h interval for three times and then exposed to room air or hyperoxia as outlined in Figure 2A . Representative histopathologic image of lungs of three mice exposed to room air or hyperoxia at 40x magnification is shown. 
